Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Glucagon Like Peptide-1 (GLP-1) Agonists

• 1.1 Definition of Glucagon Like Peptide-1 (GLP-1) Agonists
• 1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
  • 1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Exenatied
  • 1.2.3 Liraglutide
  • 1.2.4 Lixisenatide
  • 1.2.5 Abliglutide
  • 1.2.6 Dulaglutide
• 1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Applications
  • 1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Pharmacy
• 1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Overall Market
  • 1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2014-2025)
  • 1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production (2014-2025)
  • 1.4.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2014-2025)
  • 1.4.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2014-2025)
  • 1.4.5 China Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2014-2025)
  • 1.4.6 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2014-2025)
  • 1.4.8 India Glucagon Like Peptide-1 (GLP-1) Agonists Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
• 2.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
• 2.4 Industry Chain Structure of Glucagon Like Peptide-1 (GLP-1) Agonists

3 Development and Manufacturing Plants Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Glucagon Like Peptide-1 (GLP-1) Agonists
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Production and Capacity Analysis
• 4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Analysis
• 4.3 Glucagon Like Peptide-1 (GLP-1) Agonists Price Analysis
• 4.4 Market Concentration Degree

5 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Market Analysis

• 5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Production by Regions
  • 5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Regions
  • 5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Regions
• 5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Regions
• 5.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  • 5.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Production
  • 5.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export
• 5.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  • 5.4.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Production
  • 5.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export
• 5.5 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  • 5.5.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Production
  • 5.5.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export
• 5.6 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  • 5.6.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Production
  • 5.6.2 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export
• 5.7 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  • 5.7.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Production
  • 5.7.2 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export
• 5.8 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  • 5.8.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Production
  • 5.8.2 India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Glucagon Like Peptide-1 (GLP-1) Agonists Import and Export

6 Glucagon Like Peptide-1 (GLP-1) Agonists Segment Market Analysis (by Type)

• 6.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Production by Type
• 6.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type
• 6.3 Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type

7 Glucagon Like Peptide-1 (GLP-1) Agonists Segment Market Analysis (by Application)

• 7.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
• 7.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2014-2019)

8 Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers Analysis

• 8.1 Novo Nordisk
  • 8.1.1 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.1.2 Novo Nordisk Product Introduction, Application and Specification
  • 8.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 AstraZeneca
  • 8.2.1 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.2.2 AstraZeneca Product Introduction, Application and Specification
  • 8.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Eli Lily
  • 8.3.1 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.3.2 Eli Lily Product Introduction, Application and Specification
  • 8.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 GSK
  • 8.4.1 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.4.2 GSK Product Introduction, Application and Specification
  • 8.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Sanofi
  • 8.5.1 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.5.2 Sanofi Product Introduction, Application and Specification
  • 8.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Bristol-Myers Squibb
  • 8.6.1 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.6.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Amylin
  • 8.7.1 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production Sites and Area Served
  • 8.7.2 Amylin Product Introduction, Application and Specification
  • 8.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists Market

• 9.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend Analysis
  • 9.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Market Trend
  • 9.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Forecast 2019-2025
  • 9.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Forecast 2019-2025
  • 9.2.3 China Glucagon Like Peptide-1 (GLP-1) Agonists Forecast 2019-2025
  • 9.2.4 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Forecast 2019-2025
  • 9.2.5 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Forecast 2019-2025
  • 9.2.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Forecast 2019-2025
• 9.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend (Product Type)
• 9.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List